Guidelines
COVID-19

COVID-19

Notes

  • Remdesivir and baricitinib are the only FDA-approved treatments for COVID-19
  • All other recommendations herein are based on observational data, non-robust trials, and expert opinion
  • Clinical judgement should always be used to weigh the cost/benefit for individual cases

This guideline will be continually updated as more evidence is published

Clinical Management

More Information

Latest Updates

  • 11/30: Outpatient - removed bebtelovimab, EUA revoked by FDA

See Adult COVID Treatment Guidelines on the intranet microsite for references